Management of Crohn's Disease in Adults

被引:632
作者
Lichtenstein, Gary R. [1 ,2 ,3 ]
Hanauer, Stephen B. [1 ,2 ,3 ]
Sandborn, William J. [1 ,2 ,3 ]
机构
[1] Univ Chicago, Med Ctr, Dept Med, Div Gastroenterol, Chicago, IL 60637 USA
[2] Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
[3] Mayo Clin, Coll Med, Dept Med, Div Gastroenterol, Rochester, MN USA
关键词
INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; T-CELL LYMPHOMA; INFLIXIMAB PLUS AZATHIOPRINE; STEROID-DEPENDENT PATIENTS; NECROSIS-FACTOR-ALPHA; LONG-TERM EFFICACY; QUALITY-OF-LIFE; DOUBLE-BLIND; MAINTENANCE TREATMENT;
D O I
10.1038/ajg.2008.168
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Guidelines for clinical practice are intended to suggest preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When data that will withstand objective scrutiny are not available, a recommendation may be made based on a consensus of experts. Guidelines are intended to apply to the clinical situation for all physicians without regard to specialty. Guidelines are intended to be flexible, not necessarily indicating the only acceptable approach, and should be distinguished from standards of care that are inflexible and rarely violated. Given the wide range of choices in any health-care problem, the physician should select the course best suited to the individual patient and the clinical situation presented. These guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee. Expert opinion is solicited from the outset for the document. The quality of evidence upon which a specific recommendation is based is as follows: Grade A: Homogeneous evidence from multiple well-designed randomized (therapeutic) or cohort (descriptive) controlled trials, each involving a number of participants to be of sufficient statistical power. Grade B: Evidence from at least one large well-designed clinical trial with or without randomization, from cohort or case-control analytic studies, or well-designed meta-analysis. Grade C: Evidence based on clinical experience, descriptive studies, or reports of expert committees. The Committee reviews guidelines in depth, with participation from experienced clinicians and others in related fields. The final recommendations are based on the data available at the time of the production of the document and may be updated with pertinent scientific developments at a later time.
引用
收藏
页码:465 / 483
页数:19
相关论文
共 265 条
[1]   Review article: monitoring of immunomodulators in inflammatory bowel disease [J].
Aberra, FN ;
Lichtenstein, GR .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (04) :307-319
[2]   Corticosteroids and immunomodulators: Postoperative infectious complication risk in inflammatory bowel disease patients [J].
Aberra, FN ;
Lewis, JD ;
Hass, D ;
Rombeau, JL ;
Osborne, B ;
Lichtenstein, GR .
GASTROENTEROLOGY, 2003, 125 (02) :320-327
[3]   CONTROLLED TRIAL OF ANTIMYCOBACTERIAL THERAPY IN CROHNS-DISEASE - CLOFAZIMINE VERSUS PLACEBO [J].
AFDHAL, NH ;
LONG, A ;
LENNON, J ;
CROWE, J ;
ODONOGHUE, DP .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (04) :449-453
[4]   Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: Safe alternative to surgery [J].
Ajlouni, Yousef ;
Iser, John H. ;
Gibson, Peter R. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (04) :486-490
[5]  
AKOBENG AK, 2005, COCHRANE DB SYST REV, V5
[6]   Methotrexate for induction of remission in refractory Crohn's disease [J].
Alfadhli, AAF ;
McDonald, JWD ;
Feagan, BG .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)
[7]   SEGMENTAL COLONIC RESECTION IS AN APPROPRIATE OPERATION FOR SHORT SKIP LESIONS DUE TO CROHNS-DISEASE IN THE COLON [J].
ALLAN, A ;
ANDREWS, H ;
HILTON, CJ ;
KEIGHLEY, MRB ;
ALLAN, RN ;
ALEXANDERWILLIAMS, J .
WORLD JOURNAL OF SURGERY, 1989, 13 (05) :611-616
[8]   ANTIBIOTIC-THERAPY FOR TREATMENT IN RELAPSE OF INTESTINAL CROHNS-DISEASE - A PROSPECTIVE RANDOMIZED STUDY [J].
AMBROSE, NS ;
ALLAN, RN ;
KEIGHLEY, MRB ;
BURDON, DW ;
YOUNGS, D ;
BARNES, P ;
LENNARDJONES, JE .
DISEASES OF THE COLON & RECTUM, 1985, 28 (02) :81-85
[9]   Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles [J].
Anderson, PJ .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 34 (05) :19-22
[10]   Preparation and characterisation of linear dextrins and their use as substrates in in vitro studies of starch branching enzymes [J].
Andersson, L ;
Rydberg, U ;
Larsson, H ;
Andersson, R ;
Åman, P .
CARBOHYDRATE POLYMERS, 2002, 47 (01) :53-58